Skip to main content

Abstract

The activity of antibacterial agents is difficult to assess, as in contrast with other drugs, we have to deal with three components: the patient, the pathogen, and the antibiotic. As far as antibiotics are concerned, the pharmacology is separated into two distinct components, pharmacokinetics and pharmacodynamics. Pharmacokinetics describes absorption, distribution and elimination of the drug and the pharmacodynamics describes the relationship between concentration and the antimicrobial effect. The most used pharmacodynamic parameter for antibiotics is the minimal inhibitory concentration (MIC). The relationship between inhibitory concentration and the pharmacokinetics is the basis for the calculation of the three categories of sensitivity in bacteria: sensitive, intermediate, and resistant. In addition, dosing and form of application is calculated by this pharmacodynamic and pharmacokinetic parameters: oral, parenteral, infusion, bolus injection, the amount of drug, frequency of dosing, and duration of therapy. It is questionable whether such simple calculation (MIC and concentration in the serum) can describe antimicrobial activity. The pharmacokinetic data, usually available as the total serum concentration, although only the unbound concentration is active, are used for the calculation. Futhermore, infections are usually not manifest in the serum. Nevertheless, the calculation for antibiotic therapy mainly depends on concentrations in the serum. What we really need to know is the concentration of the drug in interstitial fluid, i. e. the unbound portion. A concentration-time curve at the site of infection would be even better.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Craig WA, Ebert SC (1992) Continuous infusion of f3-lactam-antibiotics. Antimicrob Agents Chemother 36: 2577–2583

    PubMed  CAS  Google Scholar 

  • Craig WA, Suh B (1991) Protein binding and the antimicrobial effects: methods of the determination of protein binding. In: Lorian V (ed) Antibiotics in laboratory medicine, 35d edn. Williams & Wilkins, Baltimore, pp 367–401

    Google Scholar 

  • Rustige C, Wiedemann B (1990) Antibacterial activity of lomefloxacin in an in vitro model. Antimicrob Agents Chemother 34: 1107–1111

    PubMed  CAS  Google Scholar 

  • Schentag JJ, Nix DE, Adelman MH (1991) Mathematical examination of dual individualization principles I: Relationship between AUC above MIC and AUG for cefmenoxime, ciprofloxacin and tobramycin. Ann Pharmacother 25: 1050–1057

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Wiedemann, B. (1997). Pharmacodynamics of Antibiotics. In: Busse, WD., Labischinski, H., Zeiler, HJ. (eds) Antibacterial Therapy: Achievements, Problems and Future Perspectives. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60803-2_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60803-2_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-62896-5

  • Online ISBN: 978-3-642-60803-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics